Maximon

Maximon empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions.

17/08/2026

Longevity is still in its early days and that’s exactly what makes the opportunity so exciting.

In a new THE HORIZONS Life Dialogue, our Co-Founder Marc P. Bernegger shares his perspective on what it takes to build and invest in longevity for the long term.
One principle stands out: science and ex*****on have to come first.
The conversation explores:
🧬 Why science- and evidence-backed solutions are essential for building sustainable longevity companies
🚀 Why great ideas alone are not enough—and strong founders and ex*****on make the difference
📈 Why longevity investing may still be approaching its tipping point
🌍 How we can make effective longevity solutions accessible to a broader public

At Maximon, this is exactly what drives our work: building impactful, science-based and scalable companies that can translate longevity innovation into measurable benefits for human health.
Thank you Nuntakorn Phitakchotiwan and THE HORIZONS life for the thoughtful conversation and for putting the spotlight on the future of longevity entrepreneurship and investment.

📖 Read the full interview here:
https://lnkd.in/et4kVvYx

05/08/2026

We’re proud of AVEA, one of our Venture Companies, which is becoming an official Premium Partner of the Swiss Indoors Basel 2026. 🎾

AVEA joins an established network of partners, including Emirates, Holcim, Sharp and IWB Industrielle Werke Basel, as a leading Swiss company in longevity and performance health.

The partnership is a natural fit. Tennis demonstrates what longevity is ultimately about: sustaining physical and mental performance over time through movement, recovery, nutrition and healthy habits.
Research supports this connection. The 2018 Copenhagen City Heart Study found that playing tennis was associated with a 9.7-year increase in life expectancy compared with a sedentary lifestyle, the highest result among the sports examined.

During the tournament, AVEA and the Swiss Indoors Basel will bring topics such as health, regeneration and long-term performance closer to visitors, connecting modern science with elite sport in a practical and engaging way.

At Maximon, we’re happy to see AVEA take longevity beyond the laboratory and into an environment that embodies resilience, discipline and sustained high performance.
Congratulations to the entire AVEA team on this achievement! 👏

06/07/2026

𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐭𝐚𝐤𝐞 𝐭𝐨 𝐛𝐮𝐢𝐥𝐝 𝐢𝐧 𝐚 𝐟𝐢𝐞𝐥𝐝 𝐛𝐞𝐟𝐨𝐫𝐞 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐟𝐮𝐥𝐥𝐲 𝐞𝐱𝐢𝐬𝐭𝐬?

In a recent interview with Unfiltered, our Founder Marc P. Bernegger shared why longevity may become one of the next major technological frontiers and what he has learned from entering emerging industries early, from the internet to Bitcoin and now healthspan innovation.

His perspective is, that real breakthroughs often begin before broad demand, market structures, or even public understanding are fully formed. That is where conviction, timing, persistence, and a strong ecosystem become essential.

For longevity, this means looking beyond today’s healthcare model and building towards a future that is more preventive, personalised, and focused on extending healthy years of life.

At Maximon, we are empowering entrepreneurs to build impactful, science-based and scalable companies that bring healthy aging and rejuvenation solutions to more people.

Thanks to Unfiltered for the exciting conversation and for highlighting why longevity is not just a trend, but a long-term transformation of health and human potential.

📖 Read the full interview via the link in the comments below.

08/06/2026

Maximon at bio:cap 2026 in Berlin

From 09–11 June 2026, bio:cap will bring together leaders from life sciences, AI, biotech, diagnostics and investment at CityCube Messe Berlin.
Maximon’s Founding Partner Marc P. Bernegger will be joining a panel discussion alongside Gregoire Biollaz, Aksana Labokha and Dr. Isabelle Schiffer to exchange perspectives on how capital, science and entrepreneurship can come together to turn breakthrough innovation into real-world impact.
At Maximon, we believe the future of longevity will be shaped at the intersection of science and business. Building impactful, science-based and scalable companies requires not only strong research, but also the right venture structures, investors and long-term conviction.
Looking forward to insightful discussions in Berlin on the future of life sciences, AI and health innovation.

📍 bio:cap – Life Science & AI Investival
🗓 09–11 June 2026
📌 CityCube Messe Berlin

08/06/2026

𝐌𝐚𝐱𝐢𝐦𝐨𝐧 𝐚𝐭 𝐛𝐢𝐨:𝐜𝐚𝐩 2026 𝐢𝐧 𝐁𝐞𝐫𝐥𝐢𝐧

From 09–11 June 2026, bio:cap will bring together leaders from life sciences, AI, biotech, diagnostics and investment at CityCube Messe Berlin.

Maximon’s Founding Partner Marc P. Bernegger will be joining a panel discussion alongside Gregoire Biollaz, Aksana Labokha and Dr. Isabelle Schiffer, Ph.D to exchange perspectives on how capital, science and entrepreneurship can come together to turn breakthrough innovation into real-world impact.

At Maximon, we believe the future of longevity will be shaped at the intersection of science and business. Building impactful, science-based and scalable companies requires not only strong research, but also the right venture structures, investors and long-term conviction.

Looking forward to insightful discussions in Berlin on the future of life sciences, AI and health innovation.

📍 bio:cap – Life Science & AI Investival
🗓 09–11 June 2026
📌 CityCube Messe Berlin

29/04/2026

The longevity field is advancing rapidly, driven by scientists, clinicians, founders, and investors who are turning decades of research into real-world impact. 🧬

has released its first-ever Rising Stars of Longevity list, highlighting 11 leaders who are helping shape the future of healthy aging across medicine, diagnostics, AI, biotech, and investment.

We are proud that , Founder of Maximon, was part of the expert panel helping evaluate the finalists alongside Andrea B. Maier, Nir Barzilai, Matt Kaeberlein, and Teresa Ghilarducci.

👏 Congratulations to the 2026 Rising Stars:
Dan Belsky, Evelyne Bischof, MD, PhD, Peter Fedichev, Celine Halioua, Jamie Justice, Ph.D., Nathan LeBrasseur, Morgan Levine, Dylan V. Livingston, Nicole Sirotin, MD DipABLM FACP, Alex Zhavoronkov, and Garri Zmudze.

What makes this list especially exciting is the diversity of perspectives represented. From biological age research and clinical translation to AI-driven discovery, preventive medicine, venture building, and investment.

Each of these leaders contributes to a broader movement: helping people live healthier for longer.

At Maximon, we believe the future of longevity will be built by those who combine rigorous science, entrepreneurial courage, and scalable solutions that can meaningfully improve healthspan.

It is inspiring to see this field gaining global recognition and even more exciting to see the people driving it forward.

Thank you to Business Insider and Hilary Brueck for spotlighting the innovators redefining how we think about aging, prevention, and human potential.💡

Adresse

Bahnhofplatz
Zug
6300

Webseite

https://www.maximon.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Maximon erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.